Views on precision transcatheter arterial chemoembolization for hepatocellular carcinoma

Ai Ning; Yang Guang; Lou Ke

Abstract：Liver cancer is one of the most common malignant tumors in the world,and its treatment is constantly optimized,among which transcatheter arterial chemoembolization(TACE)is recognized as the first choice for patients whose liver cancer cannot be surgically resected,due to its minimally invasive nature and effectiveness.In this paper,the precision and refinement of TACE technology is discussed in depth,aiming to improve its therapeutic accuracy and therapeutic effect,reduce adverse reactions,and provide patients with a more individualized treatment plan.Through a comprehensive review of TACE technology,we summarized its development history,current technologies and future trends,and emphasized the important role of precision TACE in improving treatment effectiveness and reducing patient discomfort and complications.Combined with clinical practice and case analysis,this paper describes in detail the advantages of precision TACE in practical application,and how to achieve efficient management of liver cancer through precise positioning,dose control and individualized treatment strategies.In the future,with the development of imaging technology and biomarker research,precision TACE can significantly improve the efficacy and provide clinicians and patients with safer and more effective treatment options.